Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) saw a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 6,218 shares, a drop of 71.2% from the November 30th total of 21,558 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average trading volume of 13,795 shares, the days-to-cover ratio is presently 0.5 days. Based on an average trading volume of 13,795 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.1% of the company’s shares are sold short.
Hedge Funds Weigh In On Oxbridge Re
A number of institutional investors and hedge funds have recently bought and sold shares of OXBR. Virtu Financial LLC acquired a new stake in Oxbridge Re during the 3rd quarter worth $32,000. J.W. Cole Advisors Inc. bought a new position in shares of Oxbridge Re in the 3rd quarter worth $59,000. Finally, Armistice Capital LLC acquired a new stake in shares of Oxbridge Re during the first quarter worth $1,176,000. Institutional investors own 5.64% of the company’s stock.
Oxbridge Re Stock Performance
Shares of Oxbridge Re stock opened at $1.19 on Thursday. Oxbridge Re has a twelve month low of $1.12 and a twelve month high of $5.81. The stock has a market capitalization of $9.13 million, a price-to-earnings ratio of -3.50 and a beta of 2.14. The business’s 50 day simple moving average is $1.41 and its 200-day simple moving average is $1.77.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Oxbridge Re in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $5.00.
Read Our Latest Report on OXBR
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
